Case Report: Abrocitinib treatment for refractory palmoplantar pustulosis

Xiaoyan Luo, Yaxin Huang, Mengdie Yang, Xia Xiong, Yongqiong Deng · 2026

Read Case Report: Abrocitinib treatment for refractory palmoplantar pustulosis by Xiaoyan Luo, Yaxin Huang, Mengdie Yang, Xia Xiong, Yongqiong Deng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623755.txt.

Description

Xiaoyan Luo and four co-authors report abrocitinib care for stubborn pustular disease of palms and soles. Their paper is from two thousand twenty-six. The ill brings sterile blisters back again and again, and standard drugs and biologics often fail or fade.

A woman with three years of the ill had short gains from steroids and a vitamin-A drug, then failed a mix of a pill, a cream, and light care. An immune biologic halves her scores but leaves live lesions and new itchy bumps, with blood marks of an allergy-style tilt. She swaps to abrocitinib. Scores crash near zero in weeks, the bumps clear, and blood marks settle. Control holds at four months with no ill effects.

Catalog record

CREATORXiaoyan Luo, Yaxin Huang, Mengdie Yang, Xia Xiong, Yongqiong Deng
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13623755

Browse the full library · About the Tower of Babel